Clinical Trial Update: Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This completed Phase 2 trial evaluated the combination of Vinflunine and Trastuzumab in HER2-overexpressing metastatic breast cancer; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Vinflunine (vinflunine)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-09